Newswise — PHILADELPHIA — The American Association for Cancer Research is pleased to announce Karen E. Knudsen, Ph.D., professor and Hilary Koprowski chair in the departments of cancer biology, urology and radiation oncology at Thomas Jefferson University in Philadelphia, and deputy director for basic science of the NCI-designated Kimmel Cancer Center as the new editor-in-chief of Molecular Cancer Research, one of its seven major peer-reviewed journals.

“I am honored and excited for the opportunity to lead Molecular Cancer Research,” said Knudsen, who will serve as the journal’s editor-in-chief for five years. “I hope to establish the journal as the seat of outstanding basic research related to cancer.”

Knudsen will officially begin her term in January 2013.

Molecular Cancer Research is an online and print journal that publishes original, novel and well-designed studies on the molecular and cellular aspects of cancer biology. Papers selected for publication represent new information in basic research that has implications for cancer therapeutics in angiogenesis, metastasis or genomics. The first issue of the journal was published in November 2002.

“Dr. Knudsen brings a wealth of expertise to the position of editor-in-chief of Molecular Cancer Research,” said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. “We are confident that her experience with the peer review process, coupled with her extensive knowledge of basic cancer research, will build on the journal’s success and impact in the field.”

Knudsen’s scientific accomplishments include the authorship of more than 80 peer-reviewed publications in cancer and biomedical science journals. In addition, she has authored numerous book chapters focusing on transcription and cell cycle regulation in hormone-dependent cancers. Knudsen’s research interest is predominantly prostate cancer and the molecular mechanisms that underlie tumor progression.

Throughout her career, Knudsen has been involved in both national and international scientific committees, and has held numerous leadership roles in scientific publishing, including Cancer Research. She recently received the Excellence in Mentoring Award from Thomas Jefferson University, the Richard E. Weitzman Laureate Award from the Endocrine Society and the Ron Ross Award from the Pacific Rim Breast and Prostate Cancer Foundation.

Knudsen received her doctorate from the University of California, San Diego in 1996. She trained as a postdoctoral fellow at the Ludwig Institute for Cancer Research with Webster K. Cavenee, Ph.D.

Knudsen served as assistant professor in the department of cell and cancer biology at the University of Cincinnati College of Medicine for five years and was promoted to associate professor with tenure in 2005. Two years later she joined Thomas Jefferson University as an associate professor in the departments of cancer biology and urology. In 2010, Knudsen was promoted to professor, and in addition to her duties as the deputy director of the Kimmel Cancer Center, she currently serves as the program leader for the Kimmel Cancer Center Program in Biology of Prostate Cancer.

Knudsen succeeds Michael B. Kastan, M.D., Ph.D., executive director of the Duke Cancer Institute, as editor-in-chief of the journal.

# # #

Follow the AACR on Twitter: @aacr #aacr Follow the AACR on Facebook: http://www.facebook.com/aacr.org

About the American Association for Cancer ResearchFounded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.

For more information about the AACR, visit www.AACR.org.